# Senores Pharmaceuticals – FDA Inspection, Mar 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/senores-pharmaceuticals/c0578cf6-2efc-4014-9aa6-6169353c37f8
Source feed: FDA_Inspections

> FDA inspection 1265193 of Senores Pharmaceuticals, March 28, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265193
- Company Name: Senores Pharmaceuticals
- Inspection Date: 2025-03-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/damon-a-growl/b2827f8c-e454-4db3-9285-07d11b964d5a)
- [Company Rep](https://www.keypedia.com/people/koffi-a-amegadje/817a228e-0003-43d0-bf59-71aeba0fd1f5)

Company: https://www.keypedia.com/companies/senores-pharmaceuticals/e4db9669-26bd-46cd-9d35-5f202fe3941d

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7
